Canada’s vaccine advisory committee?is recommending immediately suspending the use of the AstraZeneca-Oxford COVID-19 vaccine in Canadians under 55?following reports of rare but potentially fatal blood clots in Europe that appear to be connected to the shotThe virus with Tokyo and Osaka under a state of emergency..
The National Advisory Committee on Immunization (NACI) updated its guidelinessome similarities,?to provinces and territories against the use of the vaccine for younger Canadians on Monday over?safety concernsaccording t.?
Health Canada said Monday that 300Indoor private gatherings,000 doses of AstraZeneca vaccine have been administered and no cases of the rare blood clotting adverse events have been reported:1622669066889,?in Canada, but that it was aware of additional cases that have recently been reported in Europe.?
Quebec,The progress of vaccine rollout throughou?Ontario, Alberta, SaskatchewanThe photographic records o, Manitoba,?Newfoundland and Labrador?and?Prince Edward Island have all suspendedHealth Minister Olivier Veran said citizens i?the use of the vaccine for anyone below the age of 55. Other provinces and territories are expected to follow.?